You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • PO.6.127 Efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory t cells in patients with SLE: final results of a phase 1b multiple ascending dose study

Article metrics

Article menu

Download PDFPDF

Friday 07 October 2022 from 13:00 to 14:10
Po.6 E- poster session 6: management and recommendations, old and new therapies/biologics
PO.6.127 Efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory t cells in patients with SLE: final results of a phase 1b multiple ascending dose study

 

Online download statistics by month:

Online download statistics by month: September 2022 to August 2024

AbstractFullPdf
Sep 202260010
Oct 2022152020
Nov 2022750021
Dec 20224305
Jan 202310506
Feb 2023131018
Mar 202393013
Apr 2023114012
May 20236404
Jun 20233204
Jul 20234006
Aug 20234004
Sep 20233201
Oct 202382010
Nov 20234805
Dec 20233804
Jan 20244807
Feb 20244408
Mar 20243603
Apr 20244304
May 202448012
Jun 20245607
Jul 20244007
Aug 20242803
Total21670194